GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » Research & Development

Medizen Humancare Co (XKRX:236340) Research & Development : ₩262 Mil (TTM As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medizen Humancare Co's Research & Development for the six months ended in Dec. 2024 was ₩262 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩262 Mil.


Medizen Humancare Co Research & Development Historical Data

The historical data trend for Medizen Humancare Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co Research & Development Chart

Medizen Humancare Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 290.43 167.88 512.85 244.94 262.21

Medizen Humancare Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development Get a 7-Day Free Trial 290.43 167.88 512.85 244.94 262.21

Medizen Humancare Co Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was ₩262 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medizen Humancare Co  (XKRX:236340) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Medizen Humancare Co Research & Development Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Medizen Humancare Co Business Description

Traded in Other Exchanges
N/A
Address
Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR
Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co Headlines

No Headlines